{
  "fullName": "Pedro Cahn",
  "slug": "pedro-cahn",
  "title": "MD",
  "specialty": "Infectious Disease",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 25.66,
  "hIndex": 61,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Fundación Huésped is a nonprofit foundation in Argentina. It was created in 1989 for the purpose of fighting HIV/AIDS, with a specific focus on creating a social environment that would allow the disease to be overcome. Since October 2015, the foundation has maintained a free testing center which allows rapid diagnosis of HIV/AIDS.",
  "aiSummary": "Pedro Cahn is a infectious disease specialist with an H-index of 61 at Fundación Huésped (Member). Has been published in JAMA, The Lancet, New England Journal of Medicine. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Fundación Huésped"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Fundación Huésped",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Infectious Disease"
  ],
  "knowsAbout": [
    "National Science Award"
  ],
  "citations": [
    {
      "title": "Antiretroviral Treatment of Adult HIV Infection",
      "journal": "JAMA",
      "year": 2012,
      "citationCount": 2470,
      "doi": "10.1001/jama.2012.7961",
      "sourceUrl": "https://doi.org/10.1001/jama.2012.7961",
      "verified": true
    },
    {
      "title": "Antiretroviral Treatment of Adult HIV Infection",
      "journal": "JAMA",
      "year": 2008,
      "citationCount": 1024,
      "doi": "10.1001/jama.300.5.555",
      "sourceUrl": "https://doi.org/10.1001/jama.300.5.555",
      "verified": true
    },
    {
      "title": "Antiretroviral Treatment of Adult HIV Infection",
      "journal": "JAMA",
      "year": 2010,
      "citationCount": 724,
      "doi": "10.1001/jama.2010.1004",
      "sourceUrl": "https://doi.org/10.1001/jama.2010.1004",
      "verified": true
    },
    {
      "title": "Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study",
      "journal": "The Lancet",
      "year": 2004,
      "citationCount": 683,
      "doi": "10.1016/s0140-6736(04)15997-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(04)15997-7",
      "verified": true
    },
    {
      "title": "Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression",
      "journal": "New England Journal of Medicine",
      "year": 2020,
      "citationCount": 516,
      "doi": "10.1056/nejmoa1904398",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1904398",
      "verified": true
    },
    {
      "title": "Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial",
      "journal": "The Lancet",
      "year": 2007,
      "citationCount": 515,
      "doi": "10.1016/s0140-6736(07)61047-2",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(07)61047-2",
      "verified": true
    },
    {
      "title": "Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study",
      "journal": "The Lancet",
      "year": 2013,
      "citationCount": 507,
      "doi": "10.1016/s0140-6736(13)61221-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(13)61221-0",
      "verified": true
    },
    {
      "title": "Antiretroviral Treatment of Adult HIV Infection",
      "journal": "JAMA",
      "year": 2014,
      "citationCount": 450,
      "doi": "10.1001/jama.2014.8722",
      "sourceUrl": "https://doi.org/10.1001/jama.2014.8722",
      "verified": true
    },
    {
      "title": "Mpox in people with advanced HIV infection: a global case series",
      "journal": "The Lancet",
      "year": 2023,
      "citationCount": 448,
      "doi": "10.1016/s0140-6736(23)00273-8",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(23)00273-8",
      "verified": true
    },
    {
      "title": "Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial",
      "journal": "The Lancet",
      "year": 2011,
      "citationCount": 398,
      "doi": "10.1016/s0140-6736(11)60936-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(11)60936-7",
      "verified": true
    },
    {
      "title": "Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials",
      "journal": "The Lancet",
      "year": 2018,
      "citationCount": 371,
      "doi": "10.1016/s0140-6736(18)32462-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(18)32462-0",
      "verified": true
    },
    {
      "title": "Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials",
      "journal": "The Lancet",
      "year": 2006,
      "citationCount": 322,
      "doi": "10.1016/s0140-6736(06)69154-x",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(06)69154-x",
      "verified": true
    },
    {
      "title": "Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration",
      "journal": "PLoS Medicine",
      "year": 2005,
      "citationCount": 318,
      "doi": "10.1371/journal.pmed.0020112",
      "sourceUrl": "https://doi.org/10.1371/journal.pmed.0020112",
      "verified": true
    },
    {
      "title": "Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1",
      "journal": "PLoS Medicine",
      "year": 2004,
      "citationCount": 274,
      "doi": "10.1371/journal.pmed.0010019",
      "sourceUrl": "https://doi.org/10.1371/journal.pmed.0010019",
      "verified": true
    },
    {
      "title": "Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial",
      "journal": "The Lancet",
      "year": 2021,
      "citationCount": 228,
      "doi": "10.1016/s0140-6736(21)02753-7",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(21)02753-7",
      "verified": true
    },
    {
      "title": "Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?",
      "journal": "The Lancet",
      "year": 2008,
      "citationCount": 209,
      "doi": "10.1016/s0140-6736(08)60308-6",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(08)60308-6",
      "verified": true
    },
    {
      "title": "Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2019,
      "citationCount": 201,
      "doi": "10.1097/qai.0000000000002275",
      "sourceUrl": "https://doi.org/10.1097/qai.0000000000002275",
      "verified": true
    },
    {
      "title": "Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects",
      "journal": "AIDS",
      "year": 2003,
      "citationCount": 193,
      "doi": "10.1097/00002030-200312050-00007",
      "sourceUrl": "https://doi.org/10.1097/00002030-200312050-00007",
      "verified": true
    },
    {
      "title": "Factors associated with healthcare avoidance among transgender women in Argentina",
      "journal": "International Journal for Equity in Health",
      "year": 2014,
      "citationCount": 190,
      "doi": "10.1186/s12939-014-0081-7",
      "sourceUrl": "https://doi.org/10.1186/s12939-014-0081-7",
      "verified": true
    },
    {
      "title": "Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection",
      "journal": "New England Journal of Medicine",
      "year": 2020,
      "citationCount": 168,
      "doi": "10.1056/nejmoa1902493",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1902493",
      "verified": true
    },
    {
      "title": "Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons",
      "journal": "New England Journal of Medicine",
      "year": 2024,
      "citationCount": 163,
      "doi": "10.1056/nejmoa2411858",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2411858",
      "verified": true
    },
    {
      "title": "Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2012,
      "citationCount": 158,
      "doi": "10.1097/qai.0b013e31824d006e",
      "sourceUrl": "https://doi.org/10.1097/qai.0b013e31824d006e",
      "verified": true
    },
    {
      "title": "Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial",
      "journal": "The Lancet Infectious Diseases",
      "year": 2014,
      "citationCount": 154,
      "doi": "10.1016/s1473-3099(14)70736-4",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(14)70736-4",
      "verified": true
    },
    {
      "title": "Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV",
      "journal": "Nature Communications",
      "year": 2021,
      "citationCount": 150,
      "doi": "10.1038/s41467-021-24673-w",
      "sourceUrl": "https://doi.org/10.1038/s41467-021-24673-w",
      "verified": true
    },
    {
      "title": "Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children",
      "journal": "The Pediatric Infectious Disease Journal",
      "year": 2003,
      "citationCount": 142,
      "doi": "10.1097/01.inf.0000055061.97567.34",
      "sourceUrl": "https://doi.org/10.1097/01.inf.0000055061.97567.34",
      "verified": true
    },
    {
      "title": "Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial",
      "journal": "The Lancet HIV",
      "year": 2018,
      "citationCount": 140,
      "doi": "10.1016/s2352-3018(18)30021-3",
      "sourceUrl": "https://doi.org/10.1016/s2352-3018(18)30021-3",
      "verified": true
    },
    {
      "title": "G484S Amino Acid Substitution in Lanosterol 14-α Demethylase ( <i>ERG11</i> ) Is Related to Fluconazole Resistance in a Recurrent <i>Cryptococcus neoformans</i> Clinical Isolate",
      "journal": "Antimicrobial Agents and Chemotherapy",
      "year": 2003,
      "citationCount": 140,
      "doi": "10.1128/aac.47.11.3653-3656.2003",
      "sourceUrl": "https://doi.org/10.1128/aac.47.11.3653-3656.2003",
      "verified": true
    },
    {
      "title": "A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)",
      "journal": "Antiviral Therapy",
      "year": 2002,
      "citationCount": 137,
      "doi": "10.1177/135965350200700202",
      "sourceUrl": "https://doi.org/10.1177/135965350200700202",
      "verified": true
    },
    {
      "title": "Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme",
      "journal": "International Journal of Epidemiology",
      "year": 2007,
      "citationCount": 134,
      "doi": "10.1093/ije/dym073",
      "sourceUrl": "https://doi.org/10.1093/ije/dym073",
      "verified": true
    },
    {
      "title": "Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth",
      "journal": "AIDS",
      "year": 2006,
      "citationCount": 126,
      "doi": "10.1097/01.aids.0000253362.01696.9d",
      "sourceUrl": "https://doi.org/10.1097/01.aids.0000253362.01696.9d",
      "verified": true
    },
    {
      "title": "Prevalence of hepatitis viruses in an anti‐human immunodeficiency virus‐positive population from Argentina. Amulticentre study",
      "journal": "Journal of Viral Hepatitis",
      "year": 1999,
      "citationCount": 124,
      "doi": "10.1046/j.1365-2893.1999.t01-1-6120135.x",
      "sourceUrl": "https://doi.org/10.1046/j.1365-2893.1999.t01-1-6120135.x",
      "verified": true
    },
    {
      "title": "Discontinuation of Maintenance Therapy for Cryptococcal Meningitis in Patients with AIDS Treated with Highly Active Antiretroviral Therapy: An International Observational Study",
      "journal": "Clinical Infectious Diseases",
      "year": 2004,
      "citationCount": 124,
      "doi": "10.1086/381261",
      "sourceUrl": "https://doi.org/10.1086/381261",
      "verified": true
    },
    {
      "title": "Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2005,
      "citationCount": 118,
      "doi": "10.1097/01.qai.0000147521.34369.c9",
      "sourceUrl": "https://doi.org/10.1097/01.qai.0000147521.34369.c9",
      "verified": true
    },
    {
      "title": "Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial",
      "journal": "The Journal of Infectious Diseases",
      "year": 2003,
      "citationCount": 118,
      "doi": "10.1086/377288",
      "sourceUrl": "https://doi.org/10.1086/377288",
      "verified": true
    },
    {
      "title": "Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study",
      "journal": "The Lancet HIV",
      "year": 2017,
      "citationCount": 117,
      "doi": "10.1016/s2352-3018(17)30095-4",
      "sourceUrl": "https://doi.org/10.1016/s2352-3018(17)30095-4",
      "verified": true
    },
    {
      "title": "Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients",
      "journal": "AIDS",
      "year": 2011,
      "citationCount": 114,
      "doi": "10.1097/qad.0b013e328345ee95",
      "sourceUrl": "https://doi.org/10.1097/qad.0b013e328345ee95",
      "verified": true
    },
    {
      "title": "Expert consensus statement on the science of <scp>HIV</scp> in the context of criminal law",
      "journal": "Journal of the International AIDS Society",
      "year": 2018,
      "citationCount": 109,
      "doi": "10.1002/jia2.25161",
      "sourceUrl": "https://doi.org/10.1002/jia2.25161",
      "verified": true
    },
    {
      "title": "Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2004,
      "citationCount": 102,
      "doi": "10.1097/00126334-200406010-00005",
      "sourceUrl": "https://doi.org/10.1097/00126334-200406010-00005",
      "verified": true
    },
    {
      "title": "Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART",
      "journal": "Antiviral Research",
      "year": 2010,
      "citationCount": 101,
      "doi": "10.1016/j.antiviral.2010.05.005",
      "sourceUrl": "https://doi.org/10.1016/j.antiviral.2010.05.005",
      "verified": true
    },
    {
      "title": "Dolutegravir–lamivudine as initial therapy in HIV‐1 infected, ARV‐naive patients, 48‐week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study",
      "journal": "Journal of the International AIDS Society",
      "year": 2017,
      "citationCount": 101,
      "doi": "10.7448/ias.20.01.21678",
      "sourceUrl": "https://doi.org/10.7448/ias.20.01.21678",
      "verified": true
    },
    {
      "title": "Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society–USA Panel",
      "journal": "UNC Libraries",
      "year": 2020,
      "citationCount": 99,
      "doi": "10.17615/aypk-8k07",
      "sourceUrl": "https://doi.org/10.17615/aypk-8k07",
      "verified": true
    },
    {
      "title": "Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial",
      "journal": "The Lancet HIV",
      "year": 2019,
      "citationCount": 91,
      "doi": "10.1016/s2352-3018(19)30336-4",
      "sourceUrl": "https://doi.org/10.1016/s2352-3018(19)30336-4",
      "verified": true
    },
    {
      "title": "Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2019,
      "citationCount": 91,
      "doi": "10.1097/qai.0000000000002056",
      "sourceUrl": "https://doi.org/10.1097/qai.0000000000002056",
      "verified": true
    },
    {
      "title": "Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients",
      "journal": "PLoS ONE",
      "year": 2016,
      "citationCount": 90,
      "doi": "10.1371/journal.pone.0148231",
      "sourceUrl": "https://doi.org/10.1371/journal.pone.0148231",
      "verified": true
    },
    {
      "title": "Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent",
      "journal": "Antimicrobial Agents and Chemotherapy",
      "year": 2006,
      "citationCount": 90,
      "doi": "10.1128/aac.50.2.694-701.2006",
      "sourceUrl": "https://doi.org/10.1128/aac.50.2.694-701.2006",
      "verified": true
    },
    {
      "title": "Proposed World-Health-Organization Staging System for Hiv-Infection and Disease - Preliminary Testing by An International Collaborative Cross-Sectional Study",
      "journal": "AIDS",
      "year": 1992,
      "citationCount": 89,
      "doi": null,
      "sourceUrl": "https://openalex.org/W3033708510",
      "verified": true
    },
    {
      "title": "Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2011,
      "citationCount": 86,
      "doi": "10.1097/qai.0b013e318221c56a",
      "sourceUrl": "https://doi.org/10.1097/qai.0b013e318221c56a",
      "verified": true
    },
    {
      "title": "Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study",
      "journal": "The Lancet HIV",
      "year": 2020,
      "citationCount": 86,
      "doi": "10.1016/s2352-3018(20)30240-x",
      "sourceUrl": "https://doi.org/10.1016/s2352-3018(20)30240-x",
      "verified": true
    },
    {
      "title": "MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro",
      "journal": "Scientific Reports",
      "year": 2014,
      "citationCount": 84,
      "doi": "10.1038/srep05915",
      "sourceUrl": "https://doi.org/10.1038/srep05915",
      "verified": true
    },
    {
      "title": "The HIV care continuum in Latin America: challenges and opportunities",
      "journal": "The Lancet Infectious Diseases",
      "year": 2015,
      "citationCount": 82,
      "doi": "10.1016/s1473-3099(15)00108-5",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(15)00108-5",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5061097917",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/0/03/Fundacion-huesped-logo.png/330px-Fundacion-huesped-logo.png"
}